关于举行韩国全北国立大学Kwang-Un Jeong教授学术报告会的通知

报告题目:Multifunctional Thermoset Thin Films from Programmed Liquid Crystal Monomers 报 告 人:Kwang-Un Jeong(Chonbuk National University of Korea)报告时间:2019年1月15日上午9:30报告地点:华南软物质科学与技术高等研究院324报告厅华南软物质科学与技术高等研究院分子科学与工程学院2019年1月14日报告摘要:Anisotroptic liquid crystal networks prepared from reactive mesogens have numerous advantages in optoelectronic devices especially because of the excellent processability. To fabricate the robust LC thin films with excellent thermal, chemical and mechanical stabilities, the photo-polymerization of anisotropically pre-oriented RMs should be conducted on the optimized conditions. Since the final physical properties of anisotroptic LC networks depend on chemical functions and physical intermolecular interactions, the hierarchical superstructures of the programmed RMs with specific chemical functions should be controlled on the different length and time scales before polymerization. The presentation describes the fundamental characteristics and recent research interests of anisotropic LC networks, elastomers and gels fabricated using various programmed RMs.报告人简介:Kwang-Un Jeong received his B.S. in Fine Chemical Engineering from Chonnam National University in 1998 and M.S. in Materials Science and Engineering from Gwangju Institute of Science and Technology in 2000. After receiving his Ph.D. in Polymer Science from The University of Akron in 2005, he worked as a post-doctoral researcher for two years in the field of polymer structure and morphology under supervision of Prof. Stephen Z. D. Cheng (The University of Akron) and Prof. Edwin L. Thomas . Since 2007, he has been a professor in Chonbuk National University of Korea.

广大师生:

必发888娱乐唯一官网 ,  12月3日,第一届软物质科学与技术学术交流会在华南理工大学发光材料与器件国家重点实验室举行。来自美国梅奥医学中心的Michael J. Yaszemski教授、东华大学杨曙光教授、北京大学张文彬研究员,华南理工大学生命科学研究院王均教授、杜金志研究员,以及华南软物质科学与技术高等研究院青年教师分别作学术报告。研究院部分师生参加了报告会。

附件:

为进一步促进我校与国内外软物质研究领域学者的学术交流,华南软物质科学与技术高等研究院于2017年12月3日举行第一届软物质科学与技术学术交流会,会议分别邀请美国梅奥医学中心(Mayo Clinic)Michael J. Yaszemski教授、东华大学杨曙光教授、北京大学张文彬研究员、华南理工大学生命科学研究院杜金志研究员以及软物质研究院青年教师作学术报告。

必发888娱乐唯一官网 1 与会报告人分别做报告   与会研究人员分别介绍了在组织工程、再生医药产品领域的生物制造和商业化应用研究,分享了蛋白质基材料新研究方法、氢键键合的聚合物复合纤维的优异性质、纳米医疗手段在癌症治疗中的新进展、纳米医学领域的新进展、X射线和中子散射技术在巨型分子簇形成机理中的研究,以及制备纳米聚合物囊泡的可控手段。   这些国内外软物质领域优秀学者的报告引起了广大师生的广泛兴趣,师生们就当前国际上软物质研究领域热门方向和内容进行了积极提问。   据悉,华南软物质科学与技术高等研究院成立于2016年5月份,与学校现有的大量前沿优秀学科资源整合交叉,旨在建设成为具世界领先水平的新型研究机构。

  1. 报告时间:2017年12月3日上午9:00开始

  2. 报告地点:华南理工大学发光材料与器件国家重点实验室W502会议室

  3. 报告内容:

附:部分报告人简介   Dr. Michael J. Yaszemski is the Krehbiel Family Endowed Professor of Orthopedic Surgery and Biomedical Engineering at the Mayo Clinic and director of its Polymeric Biomaterials and Tissue Engineering Laboratory. He served as president of the Mayo Clinic medical staff from 2013-2014, and had served for 10 years as the Chair of the Spine Surgery Division of the Department of Orthopedic Surgery at Mayo Clinic Rochester prior to entering the presidential line. He received both Bachelor’s and Master’s degrees in Chemical Engineering from Lehigh University in 1977 and 1978, an M.D. from Georgetown University in 1983 and a Ph.D. in Chemical Engineering from the Massachusetts Institute of Technology in 1995. He organized and then served as the first Chair of the Musculoskeletal Tissue Engineering study section at NIH, and served as a member of the Advisory Council of the NIH National Institute of Biomedical Imaging and Bioengineering from 2010-2014. He is currently a member of the NIH Advisory Council of the National Institute of Arthritis, Musculoskeletal, and Skin Diseases. He served as Chair of the FDA Center for Devices and Radiologic Health Advisory Committee, and is currently a member of the FDA Science Board. He is an emeritus member of the Lehigh University Board of Trustees. His clinical practice encompasses spine surgery and musculoskeletal oncology. His research interests are in the synthesis and characterization of novel degradable polymers for use in bone regeneration, cartilage regeneration, nervous tissue regeneration, and controlled delivery of chemotherapeutic agents to musculoskeletal tumors.

报告题目一:Biofabrication and Commercialization of Tissue Engineering/Regenerative Medicine Products

  Wen-Bin Zhang is currently an Assistant Professor at the Department of Polymer Science and Engineering, College of Chemistry and Molecular Engineering of Peking University. He received his B.S. in Organic Chemistry from Peking University in 2004 and his Ph.D. in Polymer Science from the University of Akron in 2010. He continued at the University of Akron for his postdoctoral research under the supervision of Prof. Stephen Cheng for one year, before he moved to Caltech for a second postdoctoral training with Prof. David Tirrell in Protein Engineering and Biomaterials. His current research interests include the rational development of materials that bridges synthetic systems and biological systems for energy and health-related applications. In particular, he is interested in developing genetically encoded protein click chemistry and the use of such tools for protein topology engineering and protein-based bioactive materials.

报告人:Dr. Michael J. Yaszemski,美国Mayo Clinic

  Prof. Shuguang Yang received his BS of Chemistry (2002) at Wuhan University and PhD of Polymer Science (2007) at Institute of Chemistry, Chinese Academy of Sciences (CAS). He was research assistant (2007-2008) in Department of Polymer Science and Engineering, Peking University, and Postdoc Research Associate (2008-2010) in Department of Polymer Science, University of Akron. He has been professor of Material Science and Engineering since 2010, and associated director of Center for Advanced Low-dimension Materials, Donghua University since 2016. His academic interest is on structure and dynamics of low-dimension materials and his research is polymer complexes, coacervates, films, membrane and fibers.

报告题目二:Genetically Encoded Click Chemistry: New Tools for Protein-based Materials

报告人:张文彬研究员,北京大学

报告题目三:Hydrogen-Bonded Polymer Complex Fiber: Elastic, Conductive and Self-healing

报告人:杨曙光教授,东华大学

报告题目四:Tumor-acidity activated nanomedicine for cancer therapy